Cloning and functional characterization of the human 5‐HT2B serotonin receptor
- 5 December 2001
- journal article
- Published by Wiley
- Vol. 342 (1) , 85-90
- https://doi.org/10.1016/0014-5793(94)80590-3
Abstract
Recently, we have reported the cloning of the rat 5-HT2B receptor cDNA. This receptor is particularly interesting since it may be involved in diseases such as migraine. Here, we describe the isolation of a human 5-HT2B receptor clone from a cDNA library derived from SH-SY5Y cells. Although the receptor sequence was only 80% homologous to the rat sequence, the exon-intron distribution was conserved between the two species. In the human body, the receptor mRNA was detected in most peripheral organs. Only low expression levels were found in the brain. After expression in HEK 293 cells, activation of the receptor stimulated the production of phosphatidylinositol. The pharmacology of this functional response correlated well with that of the rodent receptor.Keywords
This publication has 32 references indexed in Scilit:
- A proposed new nomenclature for 5-HT receptorsTrends in Pharmacological Sciences, 1993
- Human serotonin1B receptor expression in Sf9 cells: Phosphorylation, palmitoylation, and adenylyl cyclase inhibitionBiochemistry, 1993
- New mouse 5‐HT2‐like receptor Expression in brain, heart and intestineFEBS Letters, 1992
- Structure of the mouse 5-HT 1c 5-HT 2 and stomach fundus serotonin receptor genesNeuroReport, 1992
- Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypesBiochemical and Biophysical Research Communications, 1991
- 5-HT1C receptor activation: a key step in the initiation of migraine?Trends in Pharmacological Sciences, 1989
- Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the ratNeuropharmacology, 1986
- Serotonergic Receptor Subtypes and Vascular ReactivityJournal of Cardiovascular Pharmacology, 1984
- Synthesis and Processing of Asparagine-Linked OligosaccharidesAnnual Review of Biochemistry, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973